The Pharmaceutical Pipeline Tracker has added new feature. You can now look up a current list of drugs with PDUFA dates and the Priority Designations for those drugs
By clicking on the “Current List of Drugs with PDUFA Dates” button on the main search screen, a scrollable list of potential budget busting investigational drugs is displayed. Included with this new feature is a single click access to the Priority Designations associated with each entity (if any). Only a select number of drugs are deemed eligible for priority review. Typically, those given priority represent significant medical breakthroughs or offer treatment where few or no other options exist. Priority review is often granted to drugs that aim to treat serious medical conditions, though drugs that treat less serious conditions are also eligible for priority review if they meet the criteria. In most cases drugs with a Priority Review are high cost specialty drugs that require special storage, administration technique, monitoring or acquisition barriers that require planning and coordination. Rather than seeking a listing of investigational drugs with PDUFA Dates separately from multiple sources (FDA, pharmacy wholesalers, pharma companies, stock analysts, primary literature) the Pharmaceutical Pipeline Tracker provides that information at the click of a single button from our main search page. Access to any Priority Designations are listed. Basic Flow – At any computer, laptop, or mobile device open a web browser and enter www.prescriberight.com in the search field then hit the enter key on the keyboard. The Home page opens. On the command line hover over “Pharmaceutical Pipeline Tracker” and click on “Access the Tracker” on the drop-down menu. Type in your assigned user name and password. Then hit the Login button. The main search screen appears, at the bottom of which is the “Current List of Drugs with PDUFA Dates” button. Click on that button and the screen displays a scrollable list of drugs with PDUFA dates. Click on any drug name to display a single drug monograph containing the following information: generic name, brand name (if available), pharma company, research code, indication, drug class, route, PDUFA Date, FDA and EU status. Statements on efficacy and safety are present. Published research studies (if available) are accessible via URL links to PubMed. Priority Designations, if any, are available by clicking on the words “Priority Designations” next to the PDUFA Date. To return to the list click on the back arrow. View as many drugs as you wish as many times as you wish. For complete details, request a FREE, no obligation trial subscription to the full Pharmaceutical Pipeline Tracker knowledgebase via the CONTACT button below. View all of our USE CASES at www.prescriberight.com. Comments are closed.
|
Stay informed, subscribe to the
Prescribe Right Pharmaceutical Pipeline Tracker Latest Tweets from Prescribe Right
Archives
May 2023
|
Services |
Company |
|
© COPYRIGHT 2015. ALL RIGHTS RESERVED.
|